Pluri INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
PLUR
Pluri INCPluri Inc.'s 2026 10-K filing reveals continued operational losses and a critical going concern warning from auditors, even as the company advances its cell therapy, FoodTech, and CDMO initiatives.
NASDAQ
PLUR
Pluri INCPluri Inc. reported a significant increase in net loss for fiscal year 2025, alongside a working capital deficit, despite revenue growth from its new CDMO and AgTech ventures.
NASDAQ
PLUR
Pluri INCPluri Inc.'s annual 10-K filing details its authorized securities, business operations across multiple sectors, and financial performance for the fiscal year ended June 30, 2024.